NCT00234065 - Post-marketing Study of Cilostazol (Cilostazol Stroke Prevention Study 2) | Biotech Hunter

Enrollment

2,800

Participants

Timeline

Start Date

December 31, 2003

Primary Completion Date

December 31, 2008

Study Completion Date

December 31, 2008

Conditions

Cerebral Infarction

Interventions

DRUG

Cilostazol

oral tablet, 100 mg twice a day and placebo of aspirin once a day, 1 to 5years

DRUG

Aspirin

oral tablet, placebo of cilostazol twice a day and 81 mg once a day, 1 to 5 years

Trial Locations (1)

Otsuka Pharmaceutical Co., Ltd., Tokyo